Anders Fink-jensen, Md, Dmsci

This study tests whether tirzepatide, a drug used for diabetes and weight loss, can reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. About 108 participants will receive either the drug or a placebo for 16 weeks, and researchers will track thei…

This study tests if semaglutide, a medicine used for diabetes and weight loss, can help adults with cannabis use disorder use less cannabis. About 100 people will get either semaglutide or a placebo for 20 weeks. The main goal is to see if the drug reduces total cannabis use comp…